Skip to main content
. 2016 Jul;8(7):1550–1560. doi: 10.21037/jtd.2016.06.04

Figure 3.

Figure 3

Progression-free survival curves. (A) Progression-free survival curves of all patients. There were no statistically significant differences between IPHC and surgery group (P=0.123); (B) progression-free survival of N0 patients. In N0 patients, progression-free survival of IPHC group was significantly higher than those of surgery group (P=0.030); (C) progression-free survival curve of N1 (+) patients; (D) progression-free survival curves of N2 (+) group. There were no significant differences between the two groups (P=0.438). IPHC, intrapleural perfusion hyperthermic chemotherapy.